These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1121805)

  • 41. [Effect of prednisolone on blood coagulation in primary glomerular diseases].
    Akiu N; Sugai K; Sato H; Saito T; Furuyama T; Akutsu Y; Mori K; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1986 Nov; 28(11):1429-36. PubMed ID: 3820820
    [No Abstract]   [Full Text] [Related]  

  • 42. [Circulating anticoagulants in systemic lupus. Apropos of 60 patients. Multicenter study conducted by the research department of the SNFMI].
    Le Thi Huong Du; Guillevin L; Arlet Suau E; Bercoff E; Pasquali JL; Beylot J; Kaloustian E; Garabedian C; Agius D; Beaugrand M
    Ann Med Interne (Paris); 1987; 138(4):246-50. PubMed ID: 3115165
    [No Abstract]   [Full Text] [Related]  

  • 43. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine.
    Mok CC; Ying KY; Mak A; To CH; Szeto ML
    Rheumatology (Oxford); 2006 Apr; 45(4):425-9. PubMed ID: 16234272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Morphological and immunohistochemical changes in the kidneys and skin in systemic lupus erythematosus during the course of treatment].
    Gritsman NN; Akhnazarova VD; Ivanova MM; Solov'ev SK
    Revmatologiia (Mosk); 1983; (2):41-5. PubMed ID: 6353514
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical and immunological studies on the exacerbation of systemic lupus erythematosus (author's transl)].
    Komeji S; Kitamura M; Kashiwazaki S
    Nihon Naika Gakkai Zasshi; 1982 Apr; 71(4):448-57. PubMed ID: 7108329
    [No Abstract]   [Full Text] [Related]  

  • 46. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Thrombotic phenomena and lupus anticoagulant in a series of 112 patients with systemic lupus erythematosus].
    Ordi Ros J; Vilardell Tarrés M; Barquinero Máñez J; Selva O'Callaghan A; Alijotas Reig J; Bosch Gil J
    Rev Clin Esp; 1987 Feb; 180(2):66-70. PubMed ID: 3105004
    [No Abstract]   [Full Text] [Related]  

  • 48. [The use of dibazol in the complex therapy of lupus erythematosus].
    Glavinskaia TA
    Vestn Dermatol Venerol; 1966 Jul; 40(7):33-6. PubMed ID: 6001633
    [No Abstract]   [Full Text] [Related]  

  • 49. [Study of rosette-forming lymphocytes in peripheral blood of patients with systemic lupus erythematosus].
    Komarov FI; Savel'ev AI; Frumina EI; Pukhal'skiĭ AL; Gutorova NM
    Ter Arkh; 1974; 46(11):78-82. PubMed ID: 4548225
    [No Abstract]   [Full Text] [Related]  

  • 50. Nitroblue tetrazolium dye reduction by peripheral leukocytes from rheumatoid arthritis and systemic lupus erythematosus patients measured by a histochemical and spectrophotometric method.
    Wenger ME; Bole GG
    J Lab Clin Med; 1973 Sep; 82(3):513-21. PubMed ID: 4728296
    [No Abstract]   [Full Text] [Related]  

  • 51. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Fluctuation of serum complement activities in systemic lupus erythematosus and its clinical significance].
    Okuda M
    Naika; 1970 Feb; 25(2):353-8. PubMed ID: 5309587
    [No Abstract]   [Full Text] [Related]  

  • 53. Lupus nephropathy.
    Mukherjee AP
    Br J Clin Pract; 1974 Apr; 28(4):127-30. PubMed ID: 4841601
    [No Abstract]   [Full Text] [Related]  

  • 54. Platelet kinetics in systemic lupus erythematosus (SLE), with special reference to corticosteroid and azathioprine therapy.
    Kutti J; Bergström AL
    Scand J Rheumatol; 1981; 10(4):266-8. PubMed ID: 7323780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The characteristics of systemic lupus erythematosus. A study in a general hospital.
    Karadsheh MF; Nimri FA; Ajlouni YM; Dneibat WA; Karadsheh RF
    Saudi Med J; 2000 Mar; 21(3):282-6. PubMed ID: 11533799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic lupus erythematosus.
    Menon ND; Sharma NN; Suri ML; Hoon RS
    J Assoc Physicians India; 1976 Sep; 24(9):573-8. PubMed ID: 1025141
    [No Abstract]   [Full Text] [Related]  

  • 57. [Tubuloreticular structures in the peripheral blood elements in systemic lupus erythematosus].
    Dreĭer EO; Alekberova ZS
    Ter Arkh; 1977; 49(8):95-8. PubMed ID: 201042
    [No Abstract]   [Full Text] [Related]  

  • 58. Thymic size in systemic lupus erythematosus. Roentgenological assessment.
    Hare WS; Mackay IR
    Arch Intern Med; 1969 Jul; 124(1):60-3. PubMed ID: 5791487
    [No Abstract]   [Full Text] [Related]  

  • 59. Interactions of prednisolone and other immunosuppressants used in dual treatment of systemic lupus erythematosus in lymphocyte proliferation assays.
    Kamal MA; Jusko WJ
    J Clin Pharmacol; 2004 Sep; 44(9):1034-45. PubMed ID: 15317831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platelet satellitism in lupus erythematosus resolving after treatment.
    Hosseinzadeh M; Kumar PV; Rahemi M
    Acta Haematol; 2006; 115(1-2):131-2. PubMed ID: 16424665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.